NYXH
Nyxoah SA (NYXH)
Healthcare • NASDAQ • $3.26+4.49%
Key Fundamentals
- Symbol
- NYXH
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $3.26
- Daily Change
- +4.49%
- Market Cap
- $142.34M
- Trailing P/E
- N/A
- Forward P/E
- -2.00
- 52W High
- $8.64
- 52W Low
- $2.76
- Analyst Target
- $10.35
- Dividend Yield
- N/A
- Beta
- 0.88
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Company websiteResearch NYXH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.